BusinessPROVECTUS BIOPHARMACEUTICALS ANNOUNCES CHANGES TO BOARD OF DIRECTORSBy Nasdaq OMXApr 24, 2018, 11:00 AM UTC
BusinessSECOND STUDY OF EXPANDED ACCESS PATIENTS TREATED WITH PV-10 FOR IN-TRANSIT MELANOMA PUBLISHED IN JOURNAL OF SURGICAL ONCOLOGYBy Nasdaq OMXApr 19, 2018, 10:00 AM UTC
BusinessStreetwise Reports Examines How One Analyst Says This Biotech Company Could Potentially 'Double'By Nasdaq OMXNov 15, 2017, 2:00 PM UTC
